{"public_id":"co_00bd925f49972f407c918c3fc9546fd0","status":"active","merged_into_public_id":null,"resolved_public_id":"co_00bd925f49972f407c918c3fc9546fd0","name":"phase II clinical trials","description":"Clinical trials that assess efficacy and further evaluate safety in a defined patient group.","aliases":["phase 2 clinical trials"],"types":["clinical trial phase"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":39899054,"title":"American Society of Clinical Oncology 2012 annual meeting update: summary of selected gynecologic cancer abstracts.","citation_count":5,"url":"https://sah.borca.ai/papers/39899054"}],"claims":[{"public_id":"cl_e13652af8fc9ec517be2a3dd6c08df06","text":"Phase II and phase III clinical trials in ovarian cancer were among the highlighted studies.","corpus_id":39899054,"url":"https://sah.borca.ai/claims/cl_e13652af8fc9ec517be2a3dd6c08df06"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_00bd925f49972f407c918c3fc9546fd0","url":"https://sah.borca.ai/concepts/co_00bd925f49972f407c918c3fc9546fd0"}